-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Perspective Therapeutics, Lowers Price Target to $8

Benzinga·05/14/2025 16:14:20
Listen to the news
Truist Securities analyst Nicole Germino maintains Perspective Therapeutics (AMEX:CATX) with a Buy and lowers the price target from $10 to $8.